Ispecimen Inc. (ISPC) Stock Price & Analysis

Ispecimen Inc. (ISPC) fell 11.66% to USD 1.97 as of July 25, 2026 at 03:08 UTC, according to Nexqual real-time market data.

ISPC last closed at USD 2.23; the session ranged USD 1.97–2.2 on volume of 48,353 shares. Market capitalization is $2.83M, with a 52-week range of USD 1.93–127.2 (NCM). Source: Nexqual, July 25, 2026 at 03:08 UTC.

Key Statistics (as of July 25, 2026 at 03:08 UTC)

Technical Analysis (ISPC)

Nexqual's technical model rates ISPC "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:08 UTC.

Analyst Ratings (ISPC)

Wall Street analysts rate ISPC "None", per Nexqual as of July 25, 2026 at 03:08 UTC.

Earnings (ISPC)

Recent Earnings History

Source: Nexqual, July 25, 2026 at 03:08 UTC.

Financials & Fundamentals (ISPC)

Source: Nexqual, July 25, 2026 at 03:08 UTC.

Financial Health Score (ISPC)

Nexqual rates Ispecimen Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 03:08 UTC.

Ownership (ISPC)

Source: Nexqual, July 25, 2026 at 03:08 UTC.

Leadership (ISPC)

Ispecimen Inc. is led by Katharyn Field (age 42), CEO, President, Secretary & Treasurer, per Nexqual as of July 25, 2026 at 03:08 UTC.

Major Backers & Investors (ISPC)

Notable institutional backers of Ispecimen Inc. include IFP Advisors, Inc, Fidelity, according to Nexqual as of July 25, 2026 at 03:08 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, July 25, 2026 at 03:08 UTC.

From Ispecimen Inc.'s Latest SEC 10-K Filing (filed 2026-04-01)

Key Strengths & Strategy (as disclosed to the SEC)

• The competitive organizations, including:             In each of these cases, the landscape is extraordinarily fragmented, and our management estimates that most biospecimen providers have less than 5% market share each, and no single biospecimen provider has more than a 20% market share.
• While we currently do not have any patents protecting our intellectual property, we rely on a combination of copyright, trademark, and trade secret laws in the United States and other jurisdictions, as well as confidentiality and non-disclosure agreements and other contractual protections with employees and third parties to protect our intellectual property rights, including our proprietary technology, brand, and know-how.
• The GDPR regulates the collection, use, disclosure, transfer, and/or other processing of personal data of identified or identifiable individuals located in the European Economic Areas, including the European Union ("EU").
• As part of this continued platform evolution, iSpecimen continues to explore adjacencies that leverage the platform including a data as a product model.   Our Technology   Technology Components   The legacy iSpecimen Marketplace has been operational for many years as an external-facing platform designed to facilitate search and matching between researchers and suppliers.

Partnerships

• We contract once with each participating customer and with each supplier organization and a single agreement then enables all users in that organization to instantly connect and work with all other organizations in the iSpecimen network.
• Recently, the Company made a strategic investment in a new technology platform built on its SalesStack solution to modernize the legacy system.   This new system introduces a cloud-native, next-generation architecture, providing a more secure, scalable, and efficient foundation for the Marketplace.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:08 UTC. This page is informational and not investment advice.